Pathstone Family Office, LLC Novo Nordisk A S Transaction History

Pathstone Family Office, LLC

$15.6 Billion
Q3 2023

A detailed history of Pathstone Family Office, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Pathstone Family Office, LLC holds 51,058 shares of NVO stock, worth $5.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

51,058

Previous 19,869 156.97%

Holding current value

$5.19 Million

Previous $3.22 Million 44.42%

% of portfolio

0.03%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$90.94 - $199.54 $2.84 Million - $6.22 Million	31,189 Added 156.97%	51,058 $4.64 Million
Q2 2023 Jan 12, 2024	SELL	$155.98 - $172.65 $4.86 Million - $5.38 Million	-31,189 Reduced 61.09%	19,869 $3.22 Million
Q2 2023 Aug 14, 2023	SELL	$155.98 - $172.65 $321,318 - $355,659	-2,060 Reduced 9.39%	19,869 $3.22 Million
Q1 2023 May 15, 2023	SELL	$132.34 - $159.14 $718,870 - $864,448	-5,432 Reduced 19.85%	21,929 $3.49 Million
Q4 2022 Oct 23, 2023	BUY	$102.55 - $135.33 $91,884 - $121,255	896 Added 3.39%	27,361 $3.7 Million
Q4 2022 Feb 13, 2023	SELL	$102.55 - $135.33 $461,680 - $609,255	-4,502 Reduced 14.13%	27,361 $3.7 Million
Q3 2022 Oct 23, 2023	BUY	$95.28 - $116.93 $644,378 - $790,797	6,763 Added 34.33%	26,465 $2.64 Million
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $618,176 - $758,641	6,488 Added 25.57%	31,863 $3.2 Million
Q2 2022 Oct 23, 2023	SELL	$103.24 - $121.81 $17,241 - $20,342	-167 Reduced 0.84%	19,702 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $976,650 - $1.15 Million	9,460 Added 59.44%	25,375 $2.83 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $108,647 - $131,334	1,167 Added 7.91%	15,915 $1.81 Million
Q4 2021 Feb 14, 2022	BUY	$95.88 - $117.08 $320,047 - $390,813	3,338 Added 29.26%	14,748 $1.65 Million
Q3 2021 Nov 16, 2021	BUY	$84.42 - $106.62 $588,069 - $742,714	6,966 Added 156.75%	11,410 $1.1 Million
Q2 2021 Aug 31, 2021	BUY	$67.66 - $84.76 $300,681 - $376,673	4,444 New	4,444 $372,000
Q1 2021 May 14, 2021	SELL	$67.06 - $75.82 $19,179 - $21,684	-286 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$63.89 - $73.8 $18,272 - $21,106	286 New	286 $20,000
Q3 2020 Nov 12, 2020	SELL	$63.69 - $70.22 $159,225 - $175,550	-2,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $144,593 - $167,811	-2,470 Reduced 49.7%	2,500 $164,000
Q1 2020 Jun 11, 2020	BUY	$49.46 - $64.78 $245,816 - $321,956	4,970 New	4,970 $300,000
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $16,376 - $18,364	-350 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$46.36 - $52.63 $16,226 - $18,420	350 New	350 $18,000
Q2 2018 Aug 10, 2018	SELL	$44.29 - $50.42 $9,743 - $11,092	-220 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $10,667 - $12,790	220 New	220 $11,000
Q3 2017 Nov 14, 2017	SELL	$41.15 - $49.22 $14,402 - $17,227	-350 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	350	350 $15,000

Others Institutions Holding NVO

# of Institutions

1,953

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $230B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.

Account

Pathstone Family Office, LLC Novo Nordisk A S Transaction History